Home/Filings/4/0001479290-20-000010
4//SEC Filing

Joshi Abhay 4

Accession 0001479290-20-000010

CIK 0001479290other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 8:12 PM ET

Size

4.9 KB

Accession

0001479290-20-000010

Insider Transaction Report

Form 4
Period: 2020-01-15
Joshi Abhay
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2020-01-15$22.89/sh4,441$101,65481,511 total
Footnotes (1)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on January 15, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock Award ("RSA") for 12,000 shares. The RSA vests in three equal annual installments from January 15, 2017, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.

Issuer

Revance Therapeutics, Inc.

CIK 0001479290

Entity typeother

Related Parties

1
  • filerCIK 0001359089

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 8:12 PM ET
Size
4.9 KB